Plain-English translation of NCT07299240 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called remote ischemic conditioning (RIC)—a non-invasive procedure that uses an inflatable cuff on your arm to briefly restrict and restore blood flow. Researchers believe this treatment may help improve sleep disturbances and other non-motor symptoms (like mood and autonomic issues) that commonly affect people with Parkinson's disease. You would receive this treatment twice daily for one week, alongside your regular Parkinson's medications.
Many people with Parkinson's disease struggle with sleep problems like insomnia, which can significantly reduce their quality of life. Current sleep medications have limited effectiveness and can cause unwanted side effects, so researchers are exploring whether this new non-invasive treatment might offer a better option.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital for two nights of sleep monitoring before the treatment begins, along with brain scans, eye imaging, and blood tests. Then you would receive the cuff treatment twice daily for 7 consecutive days—each session involves inflating a cuff on your arm to briefly reduce blood flow, then releasing it. After the week of treatment, you would return for repeat testing (sleep monitoring, scans, and blood work), and then have one final check-in about 3 weeks later to see if the benefits last.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China